ITGAX and glioma: Using this established vaccination protocol, we challenged CD11c-cre Kb cKO, CMV-cre Kb cKO, LysM-cre Kb cKO, and cre-negative littermate control animals with GL261-quad gliomas and vaccinated with TMEV-OVA intracranially (Fig. 7a).